Cannabinoid active pharmaceutical ingredient for improved dosage forms

Details for Australian Patent Application No. 2006257059 (hide)

Owner EURO-CELTIQUE S.A.

Inventors Kupper, Robert J.

Agent FB Rice

Pub. Number AU-B-2006257059

PCT Pub. Number WO2006/133941

Priority 60/726,509 12.10.05 US; 60/691,361 16.06.05 US

Filing date 14 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 11 June 2009

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/133941 Priority application(s): WO2006/133941

11 June 2009 Application Accepted

  Published as AU-B-2006257059

8 October 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 10 Sep 2009. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2008

4 February 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 10 Sep 2009

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257065-Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines

2006257058-A cap structure for a container outlet